The AI Revolution in Clinical Research: Next-Gen Precision Patient Matching

Kristin Wrobleski, PhD, Senior Director, GSK

Dr. Kristin Kahle Wrobleski is the therapeutic area lead for the anti-infectives and respiratory portfolio at GSK in the Value Evidence and Outcomes organization. She leads a team of scientists accountable for the strategic design and execution of value-focused evidence generation plans focused on the US market. Kristin previously worked at Eli Lilly and AbbVie in global value evidence roles and is committed to finding new and innovative ways to improve patient outcomes. While in a prior role at ConvergeHEALTH by Deloitte, she lent her RWE and clinical trial expertise to the development and deployment of a suite of life sciences-focused software products.

Kristin holds a PhD in clinical psychology from the University of Kansas. She completed her clinical internship at the West Los Angeles VA hospital and her post-doctoral fellowship at the Institute for Brain Aging and Dementia, University of California – Irvine.

Daniel Fort, PhD, MPH, Assoc Professor and Manager Clinical Informatics, Ochsner Center for Outcomes Research, Ochsner Health

Dan Fort operates as the Biomedical Research Informatics Specialist for the Center for Applied Health Services Research and the Ochsner Health System. His PhD was in Biomedical Informatics, specializing in clinical research informatics, particularly data modeling, clinical phenotyping algorithms and biases within electronic clinical data. He also has degrees in Health Systems Management and Biochemistry. Dan joined Ochsner after three years at Northwestern University working within their clinical and translational science unit.

Dan Housman, Chief Technology Officer, Graticule

Dan Housman is a thought leader and industry veteran in the areas of real-world data, interoperability and clinical analytics. Dan is a co-founder and CTO of Graticule, an on-demand, advanced real-world data and advisory provider serving life science companies and health systems. Throughout his career in clinical informatics, Dan has championed scalable open systems, including the distribution of the i2b2 cohort selection system, the creation of the tranSMART bioinformatics framework and the adoption of OMOP and FHIR. Previously, Dan founded Recombinant Data, a clinical data warehousing company serving health systems and pharmaceutical companies, which was acquired by Deloitte in 2012. While at Deloitte, Dan served as CTO of their healthcare analytics business, leading strategy for the ConvergeHEALTH portfolio of products. He also consulted with senior leaders at life sciences companies on innovation regarding AI in R&D and migration of patient data systems to cloud infrastructure such as Amazon Web Services.

(Moderator) Wout Brusselaers, CEO, Deep 6 AI

Wout Brusselaers is the founder and CEO of Deep 6 AI, a precision research company that empowers healthcare organizations and life sciences companies to de-risk and accelerate clinical research. Wout founded Deep 6 AI in 2016 to improve clinical trial outcomes through AI-driven software that mines electronic medical record (EMR) data to precision match patients to trials. Wout leverages his entrepreneurial experience and deep operational expertise to help address the industry’s patient recruitment and retention challenges. Wout holds a Masters in International Economics from the University College Dublin, an MFA in Film Production from Chapman University, and a Licentiate degree in Economics from Vrije Universiteit Brussel.